The Liver Study
The study drug is a potential new treatment for non-alcoholic fatty liver disease (NAFLD).
Participate in a clinical study of a potential treatment for nonalcoholic fatty liver disease (NAFLD), a range of liver conditions caused by a build-up over time of fat in the liver.
NAFLD is the most common chronic liver condition in the world, can lead to cirrhosis and liver failure. Treatment options are limited and focused on lifestyle changes.
This potential treatment would work by inhibiting an enzyme that plays a role in NAFLD, with the goal of protecting the liver from damage.
This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.
Call us on 1800 243 733 to discuss your eligibility today!